AG

Artal Group Portfolio holdings

AUM $930M
This Quarter Return
+15%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$4.57B
AUM Growth
+$4.57B
Cap. Flow
+$57.2M
Cap. Flow %
1.25%
Top 10 Hldgs %
94.28%
Holding
71
New
8
Increased
20
Reduced
1
Closed
8

Top Buys

1
GS icon
Goldman Sachs
GS
$31.4M
2
CELG
Celgene Corp
CELG
$26M
3
BAC icon
Bank of America
BAC
$13.5M
4
APTV icon
Aptiv
APTV
$13.1M
5
C icon
Citigroup
C
$10.4M

Top Sells

1
LNKD
LinkedIn Corporation
LNKD
$22.5M
2
YUM icon
Yum! Brands
YUM
$21.9M
3
MBLY
Mobileye N.V.
MBLY
$14.8M
4
GM icon
General Motors
GM
$13.6M
5
V icon
Visa
V
$13.6M

Sector Composition

1 Consumer Staples 64.63%
2 Healthcare 21.22%
3 Consumer Discretionary 10.47%
4 Financials 2.59%
5 Industrials 0.21%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
MCRB icon
26
Seres Therapeutics
MCRB
$166M
$5.98M 0.12% 225,000 +50,000 +29% +$1.33M
CLLS
27
Cellectis
CLLS
$258M
$5.78M 0.11% 210,000 – –
SPNC
28
DELISTED
Spectranetics Corp
SPNC
$5.08M 0.1% 350,000 +250,000 +250% +$3.63M
AVXS
29
DELISTED
AveXis, Inc. Common Stock
AVXS
$4.77M 0.09% +175,000 New +$4.77M
LCTX icon
30
Lineage Cell Therapeutics
LCTX
$267M
$3.68M 0.07% 1,282,050 – –
RXDX
31
DELISTED
Ignyta, Inc.
RXDX
$3.39M 0.07% 500,000 +25,000 +5% +$169K
PANW icon
32
Palo Alto Networks
PANW
$127B
$3.26M 0.06% +20,000 New +$3.26M
AGEN
33
Agenus
AGEN
$133M
$3.12M 0.06% 750,000 +200,000 +36% +$832K
CLDX icon
34
Celldex Therapeutics
CLDX
$1.47B
$2.55M 0.05% 675,000 +300,000 +80% +$1.13M
IRWD icon
35
Ironwood Pharmaceuticals
IRWD
$214M
$2.37M 0.05% 216,879 – –
CCXI
36
DELISTED
ChemoCentryx, Inc.
CCXI
$2.24M 0.04% 900,000 – –
DMTX
37
DELISTED
Dimension Therapeutics, Inc
DMTX
$2.15M 0.04% 275,000 +100,000 +57% +$783K
GLPI icon
38
Gaming and Leisure Properties
GLPI
$13.6B
$2.1M 0.04% +70,000 New +$2.1M
IBRX icon
39
ImmunityBio
IBRX
$2.21B
$1.85M 0.04% 225,000 – –
RGNX icon
40
Regenxbio
RGNX
$451M
$1.73M 0.03% 160,000 – –
PARN
41
DELISTED
Parnell Pharmaceuticals Holdings Ltd
PARN
$1.07M 0.02% 500,000 – –
IMDX
42
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$72.4M
$296K 0.01% +64,102 New +$296K
CERE
43
DELISTED
CERES, INC. COMMON STOCK NEW
CERE
$225K ﹤0.01% 1,024,020 – –
CLCD
44
DELISTED
CoLucid Pharmaceuticals, Inc.
CLCD
$35K ﹤0.01% 5,575 – –
AAPL icon
45
Apple
AAPL
$3.45T
– – 0 – –
BIIB icon
46
Biogen
BIIB
$19.4B
– – 0 – –
BMY icon
47
Bristol-Myers Squibb
BMY
$96B
– – 0 – –
GE icon
48
GE Aerospace
GE
$292B
– – 0 – –
GILD icon
49
Gilead Sciences
GILD
$140B
– – 0 – –
GM icon
50
General Motors
GM
$55.8B
– – -400,000 Closed -$13.6M
1
2
3